| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | — | +560.2% |
| Cost of Revenue | $390K | — | +216.2% |
| Gross Profit | $830K | — | +1248.8% |
| R&D Expense | $360K | — | — |
| SG&A Expense | $759K | — | +113.2% |
| Operating Income | -$2.9M | — | +27.2% |
| Net Income | -$2.8M | — | +29.5% |
| EPS (Basic) | -$0.14 | — | +48.1% |
| EPS (Diluted) | -$0.14 | — | +48.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $62K | -38.3% | +291.0% |
| Inventory | $454K | -26.2% | +44.7% |
| Current Assets | $15.6M | -13.2% | +947.8% |
| Total Assets | $16.7M | -12.4% | +354.0% |
| Current Liabilities | $1.2M | -6.3% | +34.5% |
| Long-term Debt | $146K | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.2M | — | -25.1% |
| Capital Expenditures | $48K | — | +164.2% |
| Investing Cash Flow | -$82K | — | +33.8% |
| Financing Cash Flow | -$731K | — | — |
| Free Cash Flow | -$1.2M | — | -27.7% |
| +0.0% |
| Total Liabilities | $1.3M | -5.7% | +26.4% |
| Stockholders' Equity | $15.4M | -13.0% | +483.3% |